John Buse 2018 Complete Interview

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2018  in Orlando.

John Buse, MD, PhD, is the director of the North Carolina Translational and Clinical Sciences Institute and of the UNC Diabetes Center for Excellence, professor of Medicine and Executive Associate Dean for Clinical Research at the UNC School of Medicine. His specialty is the prevention and treatment of type 1 diabetes and type 2 diabetes, and their complications. Dr. Buse’s practice combines clinical care, research and education. He has received international recognition for innovative clinical care and efforts at prevention of type 1 diabetes, type 2 diabetes and their complications. He practices patient-centered care focusing on developing treatment programs in collaboration with patients that meet their needs and expectations. He works with teams of investigators in diabetes clinical trials, comparative effectiveness research and translation of basic science research towards clinical application. Current projects focus in novel treatments including development of glucose-responsive insulin, cardiovascular safety and efficacy of diabetes drugs and developing the evidence-base for treatment guidelines of the future in diabetes care.

Featured videos include:

Pt.1: The Latest Exciting Diabetes Info

Pt.2: Observe 4D Study

Pt.3: SGLT2 Inhibitors Effects On Amputations And Cardiovascular Disease

Pt.4: Are Insurance Companies Willing To Pay For SGLT2 Inhibitors

Pt.5: Other Uses For SGLT2 Inhibitors

Pt.6: Observe 4 Study Versus Other SGLT2 Studies

Pt.7: What Do You Want Practitioners To Take Away From This Study?

Pt.8: SGLT2 Inhibitors For Type 1 Diabetes

 or view the complete interview here: Full Interview.

To read the transcript of the full interview, click here.